Multiple small lymph nodes in bilateral inguinal regions in female

Feb 11, 2023 Source: Cainiu Health
Dr. Li Feng
Introduction
Multiple small lymph nodes in the bilateral inguinal regions of women may be caused by inflammation, reactive hyperplasia, or tumors. They could result from urinary tract infections, gynecological inflammations, or skin injuries in the lower limbs. Inflammatory stimuli or infections may lead to changes in multiple small inguinal lymph nodes bilaterally. In such cases, anti-inflammatory treatment is generally the primary approach.

Multiples small lymph nodes in the bilateral inguinal regions of women may be caused by inflammation, reactive hyperplasia, or tumors.

1. Inflammation

If there is inflammation of the urinary system, gynecological infections in women, lower limb skin injuries, or similar conditions, inflammatory stimulation and infection can lead to changes in multiple small lymph nodes in the bilateral inguinal area. Anti-inflammatory treatment is required, which may include oral administration of anti-inflammatory medications under a doctor's guidance. Commonly used drugs include levofloxacin tablets, cefmenoxime tablets, and piperacillin sodium tablets. For more severe cases with concurrent infection or fever, intravenous infusion may be used for symptomatic treatment.

2. Reactive Hyperplasia

When primary lesions exist elsewhere in the body—for example, lower limb trauma and infection in patients—inflammatory cells may proliferate and spread, causing an inflammatory response in the inguinal lymph nodes. Under inflammatory stimulation, this can result in multiple small inguinal lymph nodes. It is important to promptly undergo a comprehensive systemic examination at a hospital to identify the underlying cause and actively cooperate with treatment.

3. Tumor

In clinical cases of malignant tumors, cancer cells may spread and metastasize to lymphatic areas, resulting in multiple small lymph nodes in the bilateral inguinal regions. Timely radiotherapy, chemotherapy, or targeted therapy should be administered under medical supervision.